Preclinical Evaluation of Ga-DOTA-Minigastrin for the Detection of Cholecystokinin-2/Gastrin Receptor-Positive Tumors
In comparison to somatostatin receptor scintigraphy, gastrin receptor scintigraphy using 111 In-DTPA-minigastrin (MG0) showed added value in diagnosing neuroendocrine tumors. We investigated whether the 68 Ga-labeled gastrin analogue DOTA-MG0 is suited for positron emission tomography (PET), which c...
Saved in:
| Main Authors: | Maarten Brom, Lieke Joosten, Peter Laverman, Wim J.G. Oyen, Martin Béhé, Martin Gotthardt, Otto C. Boerman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2011-03-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.2310/7290.2010.00032 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro and In Vivo Characterization of Three Ga- and In-Labeled Peptides for Cholecystokinin Receptor Imaging
by: Susan Roosenburg, et al.
Published: (2012-09-01) -
Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
by: Camila Gadens Zamboni, et al.
Published: (2024-11-01) -
Antral Gastrin Cell Hyperfunction Associated with Chronic Pancreatitis
by: Atilla Ertan, et al.
Published: (1988-01-01) -
BRAIN CHOLECYSTOKININ SYSTEM IN NEUROTIC PATHOLOGY
by: R.V. Lutsenko, et al.
Published: (2023-04-01) -
Evaluation of 68Ga-DOTA-Ubiquicidin (29–41) for imaging Staphylococcus aureus (Staph A) infection and turpentine-induced inflammation in a preclinical setting
by: Dilip Kumar Boddeti, et al.
Published: (2021-07-01)